Filing Flows › Merit Medical Systems (MMSI) › Capital expenditures
Merit Medical Systems (MMSI) capital expenditures by quarter
Merit Medical Systems' capital expenditures were $12.3M in Q3 2026 (third quarter 2026), -29% from Q2 2026. Over the last 7 quarters it ranged from $12.3M (Q3 2026) to $24.5M (Q4 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $12.3M | -29% | -45% |
| Q2 2026 | $17.3M | +8% | +26% |
| Q1 2026 | $16.0M | -35% | -24% |
| Q4 2025 | $24.5M | +9% | — |
| Q3 2025 | $22.4M | +63% | — |
| Q2 2025 | $13.8M | -35% | — |
| Q1 2025 | $21.1M | — | — |
Q3 2026 at a glance
Merit Medical Systems, Q3 2026: revenue $416M (+8% year over year), operating margin 14.1%, net earnings $42.3M, operating cash flow $65.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Merit Medical Systems' capital expenditures?
Merit Medical Systems' capital expenditures were $12.3M in Q3 2026 (third quarter 2026), -29% from Q2 2026.
How has Merit Medical Systems' capital expenditures changed?
Over the last 7 quarters it ranged from $12.3M (Q3 2026) to $24.5M (Q4 2025).